Genetically predicted testosterone and systemic inflammation in men: A separate-sample Mendelian randomization analysis in older Chinese men

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Zhao, Jie ^a   Jiang, Chaoqiang ^b   Lam, Tai Hing ^a   Liu, Bin ^b   Cheng, Kar Keung ^c   Xu, Lin ^a   Yeung, Shiu Lun Au ^a   Zhang, Weisen ^b   Leung, Gabriel M ^a   Schooling, C Mary ^a,d  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b Guangzhou Number 12 Hospital   (China)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; GENETICS; GRANULOCYTE; HUMAN; INFLAMMATION; LEUKOCYTE; LYMPHOCYTE; MALE; MENDELIAN RANDOMIZATION ANALYSIS; PREDICTION; SINGLE NUCLEOTIDE POLYMORPHISM; TESTOSTERONE BLOOD LEVEL; CHINA; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHINA; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TESTOSTERONE;

EID: 84929180117     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126442     Document Type: Article

References (39)

1. Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science. 2013; 339: 166-172. doi: 10.1126/science.1230720 PMID: 23307734
2. Dougherty TF. Effect of hormones on lympatic tissue. Physiol Rev. 1952; 32: 379-401. PMID: 13003534
3. Korenchevsky V, Dennison M, Schalit R. The response of castrated male rats to the injection of testicular hormone. Biochem J. 1932; 26: 1306-1314. PMID: 16744939
4. Jee SH, Park JY, Kim HS, Lee TY, Samet JM. White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans. Am J Epidemiol. 2005; 162: 1062-1069. PMID: 16221804
5. Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Salonen JT. C-reactive protein in the prediction of cardiovascular and overall mortality in middle-aged men: a population-based cohort study. Eur Heart J. 2005; 26: 1783-1789. PMID: 15821003
6. Haring R, Baumeister SE, Volzke H, Dorr M, Kocher T, Nauck M, et al. Prospective inverse associations of sex hormone concentrations in men with biomarkers of inflammation and oxidative stress. J Androl. 2012; 33: 944-950. PMID: 22207707
7. Gannage-Yared MH, Chedid R, Abs L. Relation between androgens and cardiovascular risk factors in a young population. Clin Endocrinol (Oxf). 2011; 74: 720-725. doi: 10.1111/j.1365-2265.2011.03987.x PMID: 21521259
8. Brand JS, van der Schouw YT, Dowsett M, Folkerd E, Luben RN, Wareham NJ, et al. Testosterone, SHBG and differential white blood cell count in middle-aged and older men. Maturitas. 2012; 71: 274-278. doi: 10.1016/j.maturitas.2011.12.007 PMID: 22221653
9. Schneider HJ, Sievers C, Klotsche J, Bohler S, Pittrow D, Lehnert H, et al. Prevalence of low male testosterone levels in primary care in Germany: cross-sectional results from the DETECT study. Clin Endocrinol (Oxf). 2009; 70: 446-454. doi: 10.1111/j.1365-2265.2008.03370.x PMID: 18691272
10. Sheehan NA, Didelez V, Burton PR, Tobin MD. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 2008; 5: e177. doi: 10.1371/journal.pmed.0050177 PMID: 18752343
11. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002; 87: 589-598. PMID: 11836290
12. Shi Z, Araujo AB, Martin S, O'Loughlin P, Wittert GA. Longitudinal changes in testosterone over five years in community-dwelling men. J Clin Endocrinol Metab. 2013; 98: 3289-3297. doi: 10.1210/jc.2012-3842 PMID: 23775354
13. Frederiksen L, Glintborg D, Hojlund K, Hougaard DM, Brixen K, Rasmussen LM, et al. Osteoprotegerin Levels Decrease During Testosterone Therapy in Aging Men and are Associated with Changed Distribution of Regional Fat. Horm Metab Res. 2013; 45: 308-313. doi: 10.1055/s-0032-1323647 PMID: 22918704
14. Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007; 156: 595-602. PMID: 17468196
15. Nakhai-Pour HR, Grobbee DE, Emmelot-Vonk MH, Bots ML, Verhaar HJ, van der Schouw YT. Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial. Am Heart J. 2007; 154: 1228 e1221-1227. PMID: 18035098
16. Kalinchenko SY, Tishova YA, Mskhalaya GJ, Gooren LJ, Giltay EJ, Saad F. Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study. Clin Endocrinol (Oxf). 2010; 73: 602-612. doi: 10.1111/j.1365-2265.2010.03845.x PMID: 20718771
17. Panizzon MS, Hauger R, Jacobson KC, Eaves LJ, York TP, Prom-Wormley E, et al. Genetic and environmental influences of daily and intra-individual variation in testosterone levels in middle-aged men. Psychoneuroendocrinology. 2013; 38: 2163-2172. doi: 10.1016/j.psyneuen.2013.04.003 PMID: 23639251
18. Zhao J, Jiang C, Lam TH, Liu B, Cheng KK, Xu L, et al. Genetically predicted testosterone and cardiovascular risk factors in men: a Mendelian randomization analysis in the Guangzhou Biobank Cohort Study. Int J Epidemiol. 2014; 43: 140-148. doi: 10.1093/ije/dyt239 PMID: 24302542
19. Jiang C, Thomas GN, Lam TH, Schooling CM, Zhang W, Lao X, et al. Cohort profile: The Guangzhou Biobank Cohort Study, a Guangzhou-Hong Kong-Birmingham collaboration. Int J Epidemiol. 2006; 35: 844-852. PMID: 16844769
20. Au Yeung SL, Jiang CQ, Cheng KK, Liu B, Zhang WS, Lam TH, et al. Evaluation of moderate alcohol use and cognitive function among men using a Mendelian randomization design in the Guangzhou biobank cohort study. Am J Epidemiol. 2012; 175: 1021-1028. doi: 10.1093/aje/kwr462 PMID: 22302076
21. Schooling CM, Jiang CQ, Lam TH, Zhang WS, Cheng KK, Leung GM. Childhood meat eating and inflammatory markers: the Guangzhou Biobank Cohort Study. BMC Public Health. 2011; 11: 345. doi: 10.1186/1471-2458-11-345 PMID: 21595911
22. Jiang CQ, Lam TH, Lin JM, Liu B, Yue XJ, Cheng KK, et al. An overview of the Guangzhou biobank cohort study-cardiovascular disease subcohort (GBCS-CVD): a platform for multidisciplinary collaboration. J Hum Hypertens. 2010; 24: 139-150. doi: 10.1038/jhh.2009.52 PMID: 19587700
23. Stock JH, Yogo M. Testing for Weak Instruments in Linear IV Regression. Cambridge, MA: National Bureau of Economic Research; 2002.
24. Tchetgen Tchetgen EJ, Walter S, Glymour MM. Commentary: building an evidence base for mendelian randomization studies: assessing the validity and strength of proposed genetic instrumental variables. Int J Epidemiol. 2013; 42: 328-331. doi: 10.1093/ije/dyt023 PMID: 23508417
25. Freeman G, Cowling BJ, Schooling CM. Power and sample size calculations for Mendelian randomization studies using one genetic instrument. Int J Epidemiol. 2013; 42: 1157-1163. doi: 10.1093/ije/dyt110 PMID: 23934314
26. Pierce BL, Ahsan H, Vanderweele TJ. Power and instrument strength requirements for Mendelian randomization studies using multiple genetic variants. Int J Epidemiol. 2011; 40: 740-752. doi: 10.1093/ije/dyq151 PMID: 20813862
27. van der Poll T, Romijn JA, Endert E, Sauerwein HP. Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men. Metabolism. 1993; 42: 303-307. PMID: 8487647
28. Pierce BL, Burgess S. Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable Estimators. Am J Epidemiol. 2013; 178: 1177-1184. doi: 10.1093/aje/kwt084 PMID: 23863760
29. Taylor AE, Davies NM, Ware JJ, Vanderweele T, Smith GD, Munafo MR. Mendelian randomization in health research: Using appropriate genetic variants and avoiding biased estimates. Econ Hum Biol. 2014; 13: 99-106. doi: 10.1016/j.ehb.2013.12.002 PMID: 24388127
30. Schroderus E, Jokinen I, Koivula M, Koskela E, Mappes T, Mills SC, et al. Intra- and Intersexual Trade-Offs between Testosterone and Immune System: Implications for Sexual and Sexually Antagonistic Selection. American Naturalist. 2010; 176: E90-E97. doi: 10.1086/656264 PMID: 20712516
31. Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med. 2013; 368: 138-148. doi: 10.1056/ NEJMoa1209096 PMID: 23228172
32. Vandenput L, Labrie F, Mellstrom D, Swanson C, Knutsson T, Peeker R, et al. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. J Bone Miner Res. 2007; 22: 220-227. PMID: 17059374
33. Schooling CM. Androgen activity and markers of inflammation among men in NHANES III. Am J Hum Biol. 2013; 25: 622-628. doi: 10.1002/ajhb.22421 PMID: 23943465
34. Samy N, Hashim M, Sayed M, Said M. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index. Dis Markers. 2009; 26: 163-170. doi: 10.3233/DMA-2009-0627 PMID: 19729797
35. Tsang S. A modern history of Hong Kong. Hong Kong: Hong Kong University Press; 2004.
36. Fernandez-Balsells MM, Murad MH, Lane M, Lampropulos JF, Albuquerque F, Mullan RJ, et al. Clinical review 1: Adverse effects of testosterone therapy in adult men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2010; 95: 2560-2575. doi: 10.1210/jc.2009-2575 PMID: 20525906
37. Muraleedharan V, Jones TH. Testosterone and the metabolic syndrome. Ther Adv Endocrinol Metab. 2010; 1: 207-223. doi: 10.1177/2042018810390258 PMID: 23148165
38. Bennett DA. An introduction to instrumental variables-part 2: Mendelian randomisation. Neuroepidemiology. 2010; 35: 307-310. doi: 10.1159/000321179 PMID: 21042034
39. Burgess S, Thompson SG, Collaboration CCG. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011; 40: 755-764. doi: 10.1093/ije/dyr036 PMID: 21414999